Company Filing History:
Years Active: 2022-2025
Title: Innovations by Kathy Dao in MCL1 Inhibitors
Introduction
Kathy Dao is an accomplished inventor based in San Mateo, CA. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of MCL1 inhibitors. With a total of three patents to her name, Kathy has established herself as a key figure in her area of expertise.
Latest Patents
Kathy's latest patents focus on processes and intermediates for preparing MCL1 inhibitors. The present disclosures provide methods for preparing MCL1 inhibitors or a salt thereof, along with related key intermediates. These innovations are crucial for advancing therapeutic options in treating various diseases.
Career Highlights
Kathy Dao works at Gilead Sciences, Inc., a leading biopharmaceutical company. Her role involves extensive research and development, contributing to the company's mission of improving patient outcomes through innovative therapies. Her expertise and dedication have been instrumental in the progress of her projects.
Collaborations
Throughout her career, Kathy has collaborated with talented professionals, including her coworkers Katrien Brak and Kae M Bullock. These collaborations have fostered a dynamic research environment, allowing for the exchange of ideas and the advancement of their collective work in the field.
Conclusion
Kathy Dao's contributions to the development of MCL1 inhibitors highlight her innovative spirit and commitment to advancing medical science. Her work at